DBK:XETRDeutsche Bank Aktiengesellschaft Analysis
Data as of 2026-05-24 - not real-time
€28.17
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Deutsche Bank trades at a trailing P/E of 8.9, well below the industry average of 16.8, and a price‑to‑book of 0.68, indicating a clear valuation gap. The stock yields 3.55% dividend with a modest payout ratio of 21.5%, and technicals show a bullish MACD histogram (+0.14) and an RSI of 59, suggesting limited downside while the price sits near the identified resistance of €28.35 and above the support of €25.80. Volatility remains elevated at ~28% over the past 30 days, but a beta of 0.68 points to lower systematic risk relative to the market.
The consensus analyst view is a “buy” with a median target of €33.5, implying upside of roughly 16% from the current €28.17 price. Risks stem from the banking sector’s regulatory environment and European macro‑economic exposure, yet the strong cash position, low leverage and sustainable dividend support a positive outlook across short‑, medium‑ and long‑term horizons.
The consensus analyst view is a “buy” with a median target of €33.5, implying upside of roughly 16% from the current €28.17 price. Risks stem from the banking sector’s regulatory environment and European macro‑economic exposure, yet the strong cash position, low leverage and sustainable dividend support a positive outlook across short‑, medium‑ and long‑term horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD with modest histogram expansion
- Price approaching short‑term resistance at €28.35
- Elevated 30‑day volatility limiting upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount vs peers (P/E 8.9 vs 16.8)
- Attractive dividend yield and low payout ratio
- Analyst consensus target median €33.5 indicating ~16% upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong balance‑sheet with ample cash and low leverage
- Sustainable dividend providing steady income
- Long‑term price‑to‑book below 1 suggesting capital appreciation potential
Key Metrics & Analysis
Financial Health
Revenue Growth1.20%
Profit Margin22.65%
P/E Ratio8.9
ROE8.65%
ROA0.48%
P/B Ratio0.7
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI59.5
Support€25.80
Resistance€28.35
MA 20€27.09
MA 50€26.74
MA 200€29.97
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Target Price€32.77
Upside/Downside16.36%
GradeUndervalued
TypeValue
Dividend Yield3.55%
Risk Assessment
Beta0.68
Volatility28.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.